Literature DB >> 22458750

The salt controversy and hypertension.

Debbie L Cohen1, Raymond R Townsend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22458750      PMCID： PMC8108897          DOI： 10.1111/j.1751-7176.2012.00594.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  9 in total

1.  Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension.

Authors:  Tatiana Kuznetsova; Jan A Staessen; Kalina Kawecka-Jaszcz; Speranta Babeanu; Edoardo Casiglia; Jan Filipovsky; Choudomir Nachev; Yuri Nikitin; Jan Peleskã; Eoin O'Brien
Journal:  Blood Press Monit       Date:  2002-08       Impact factor: 1.444

Review 2.  Sodium, blood pressure, and cardiovascular disease.

Authors:  Hillel W Cohen; Michael H Alderman
Journal:  Curr Opin Cardiol       Date:  2007-07       Impact factor: 2.161

3.  Relative contributions of dietary sodium sources.

Authors:  R D Mattes; D Donnelly
Journal:  J Am Coll Nutr       Date:  1991-08       Impact factor: 3.169

4.  Urinary sodium and potassium excretion and risk of cardiovascular events.

Authors:  Martin J O'Donnell; Salim Yusuf; Andrew Mente; Peggy Gao; Johannes F Mann; Koon Teo; Matthew McQueen; Peter Sleight; Arya M Sharma; Antonio Dans; Jeffrey Probstfield; Roland E Schmieder
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

5.  Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population.

Authors:  J A Staessen; J G Wang; E Brand; C Barlassina; W H Birkenhäger; S M Herrmann; R Fagard; L Tizzoni; G Bianchi
Journal:  J Hypertens       Date:  2001-08       Impact factor: 4.844

6.  Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.

Authors:  Katarzyna Stolarz-Skrzypek; Tatiana Kuznetsova; Lutgarde Thijs; Valérie Tikhonoff; Jitka Seidlerová; Tom Richart; Yu Jin; Agnieszka Olszanecka; Sofia Malyutina; Edoardo Casiglia; Jan Filipovský; Kalina Kawecka-Jaszcz; Yuri Nikitin; Jan A Staessen
Journal:  JAMA       Date:  2011-05-04       Impact factor: 56.272

7.  Application of lower sodium intake recommendations to adults--United States, 1999-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-03-27       Impact factor: 17.586

8.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

9.  Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Authors:  S Yusuf; K Teo; C Anderson; J Pogue; L Dyal; I Copland; H Schumacher; G Dagenais; P Sleight
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321
  9 in total
  1 in total

Review 1.  Essential hypertension: an approach to its etiology and neurogenic pathophysiology.

Authors:  Juan J Bolívar
Journal:  Int J Hypertens       Date:  2013-12-09       Impact factor: 2.420
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.